Associate Professor Martin Stockler
|
Associate Professor
C39 - Royal Prince Alfred Hospital |
|
Research interests
Improving quality of life, survival, prognostication, and doctor-patient communication for those affected by cancer, particularly genitourinary (prostate, testis, kidney, bladder), breast and lung. Clinical trials, meta-analaysis, evidence based medicine, biostatistics.
Current national competitive grants*
2011
START Trial: Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed with Favourable Risk Prostate Cancer
Millar J, Bolton D, Frydenberg M, Patel M, Williams S, Davis I, Stockler M
Cancer Australia Priority-driven Collaborative Cancer Research Scheme ($598,764 over 3 years)
Using scenarios to estimate and explain survival time to people with incurable cancer
Kiely B, Stockler M
American Society of Clinical Oncology (USA) Young Investigator Award ($50,000 over 0 years)
NITRO: A Phase III, randomised trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer
Davidson A, Boyer M, Millward M, Fong K, McLachlan S, Singhal N, Stockler M
Cancer Australia Priority-driven Collaborative Cancer Research Scheme ($596,747 over 3 years)
2008
Clinical trials advances for better health outcomes
Simes J, Keech A, Gebski V, Stockler M
NHMRC Project Grant ($7,560,000 over 5 years)
* Grants administered through the University of Sydney